Atom Investors LP Celldex Therapeutics, Inc. Transaction History

Atom Investors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $230,106 - $298,941	7,024 Added 15.56%	52,164 $1.93 Million
Q1 2024 May 15, 2024	BUY	$35.22 - $51.88 $149,966 - $220,905	4,258 Added 10.42%	45,140 $1.89 Million
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $924,342 - $1.66 Million	40,882 New	40,882 $1.62 Million
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $198,176 - $270,256	5,698 New	5,698 $205,000
Q1 2022 May 16, 2022	SELL	$27.64 - $39.32 $297,986 - $423,908	-10,781 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $384,666 - $606,646	10,781 New	10,781 $417,000

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.